Advertisement

Topics

Elusys Therapeutics, Inc Company Profile

04:13 EST 22nd November 2017 | BioPortfolio

Elusys Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of targeted anti-infective therapeutics using proprietary Heteropolymer (HP) Antibodies for the treatment of infectious disease. The Company’s most advanced product, Anthim™, a treatment for Anthrax infection, has entered Phase I human safety studies. Anthim represents a near-term revenue opportunity as it is a strong candidate for purchase by the U.S. Government under Project BioShield.

Location

P.O. Box 102 25 Riverside Drive
Pine Brook
New Jersey
07058
United States of America

Contact

Phone: 973.808.0222
Fax: 973.808.0322
Email: mailto:info@elusys.com


News Articles [530 Associated News Articles listed on BioPortfolio]

Elusys Therapeutics, Inc. Delivers First Shipment Of Anthim, Its Treatment For Inhalation Anthrax, To The Strategic National Stockpile

  Life Sciences Jobs   ...

Elusys Delivers First Shipment Of ANTHIM®, Its Treatment For Inhalation Anthrax, To The U.S. Government Strategic National Stockpile

PINE BROOK, N.J., Oct. 10, 2017 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys) announced today that the company has delivered the first doses of ANTHIM® (obiltoxaximab) Injection, its treatm...

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Deals this week: Nabriva Therapeutics, LifeMine Therapeutics, Aldeyra Therapeutics

Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.

ProQR spins out Amylon Therapeutics for CNS therapeutics

ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...

Breakfast Technical Briefing on Biotech Stocks -- Cytori Therapeutics, Sorrento Therapeutics, ...

http://dailystocktracker.com/register/ Cytori Therapeutics San Diego, Californiaheadquartered Cytori Therapeutics Inc.'s shares dropped 2.15%, closing Monday's trading session at $0.39. The stock ...

RaNA Therapeutics Relaunches as Translate Bio to Advance RNA Therapeutics

Tuesday, June 27th 2017 at 11:00am UTC — Company Expands Executive Leadership Team with Key Appointments in Early 2017 — CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics tod...

SMi Group announces the 9th Annual RNA Therapeutics Conference

21 - 22 February 2018, London, UK. As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towar...

Clinical Trials [121 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1169 Associated Companies listed on BioPortfolio]

Elusys Therapeutics, Inc.

Elusys Therapeutics, a private company based in Pine Brook, New Jersey, is focused on the development of antibody therapeutics for the treatment of life-threatening disease. Current investors include ...

Elusys Therapeutics, Inc

Elusys Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of targeted anti-infective therapeutics using proprietary Heteropolymer (HP) Antibodies for the treat...

EluSys Therapeutics Incorporated

EluSys Therapeutics, Inc. is focused on the development and commercialization of the EluSys Heteropolymer System (the "Technology" or "HP System"), a novel platform technology to treat a wide variety...

Elusys Therapeutics

Alliance for Biosecurity

The Alliance for Biosecurity was formed in June of 2005 by biopharmaceutical companies and the Center for Biosecurity of the University of Pittsburgh Medical Center. Alliance members are committed to...

More Information about "Elusys Therapeutics, Inc" on BioPortfolio

We have published hundreds of Elusys Therapeutics, Inc news stories on BioPortfolio along with dozens of Elusys Therapeutics, Inc Clinical Trials and PubMed Articles about Elusys Therapeutics, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Elusys Therapeutics, Inc Companies in our database. You can also find out about relevant Elusys Therapeutics, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record